Dr. David Sugarbaker will be honored with the Pioneer Award by the Meso Foundation for his lifetime work in mesothelioma research and treatment development.
Considered one of the world’s leading experts on the topic, Dr. Sugarbaker serves as the Chief Division of Thoracic Surgery, and as the founder and Director of the International Mesothelioma Program (IMP) at Brigham and Women’s Hospital in Boston.
The Meso Foundation presents awards to individuals who contribute to research and advocacy for mesothelioma.
The Pioneer Award will be presented at the foundation’s annual symposium on July 12-13 in Washington D.C.
Additional notable guests of the event include Raja Flores, MD, Stephen Hahn, MD, Raffit Hassan, MD, Robert Kratzke, MD, Harvey Pass, MD, Daniel Sterman, MD and Robert Taub, MD, PhD, in addition to others.
Sugarbaker has become an outspoken advocate for the use of a surgical procedure known as extrapleural pneumonectomy (EPP). This is serious surgery option involves removing the lung, diaphragm or chest cavity lining, with the goal of removing tumors and reducing the spread of cancerous cells.
His work has allowed some patients to live better lives.
The Meso Foundation, also known as known as the Mesothelioma Applied Research Foundation, defined the doctor’s success through more than the novel treatment approaches, but also through his contributions to the medical community in peer-reviewed journals.
“He has trained many young surgeons and has inspired countless others to remain committed to research and treatment,” the foundation said in its announcement.